Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Intrathecal rituximab for the treatment of Epstein-Barr virus-associated encephalitis.
Journal: Frontiers in immunology
Published: November 04, 2025
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 03, 2025
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy.
Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 19, 2024
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas.
Journal: Molecular cancer therapeutics
Published: July 06, 2024
211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 31, 2024
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Journal: European journal of haematology
Published: June 19, 2023
[211At]astatine-based anti-CD22 radioimmunotherapy for B-cell malignancies.
Journal: Leukemia & lymphoma
Published: May 12, 2023
Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 02, 2023
Last Updated: 09/26/2026